Can a smart glucose monitor keep diabetics out of the hospital?

NCT ID NCT07221812

Not yet recruiting Disease control Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving people with diabetes a continuous glucose monitor (CGM) when they leave the hospital helps them control their blood sugar better than traditional finger-stick testing. 120 participants will be randomly assigned to use either a CGM or finger sticks for 3 months after discharge. The goal is to see if the CGM leads to fewer hospital readmissions and better overall glucose management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Continuous Glucose Monitor (Dexcom G7)
What this could lead to: If successful, this could show that using CGMs after hospital discharge helps people with diabetes better control their blood sugar and avoid returning to the hospital.
What could go wrong: This is a small, early-stage study (120 people) at a single VA center, so results may not apply to everyone. The device itself is generally safe, but false alarms or user error could cause stress or incorrect treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES (DM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES (DM)

Contacts and locations

Locations

Baltimore VA Medical Center

Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.